Table 2. Univariable and multivariable analyses for persistent LV systolic dysfunction.

	Univariable			Multivariable
	OR	95% C.I.	p	OR	95% C.I.	p
Agea	1.06	1.01–1.11	0.015
Heart Ratea	0.96	0.93–0.98	0.001
SBPa	1.10	1.020–1.192	0.014
Non-fulminant forms (if surviving to the acute phase)	14.87	3.60–61.39	<0.001	8.46	1.28–55.75	0.013
Poor Lymphocytic Infiltrate	9.45	1.77–50.47	0.009	12.4	1.23–124.97	0.010
Baseline LVEDDa	1.19	1.06–1.34	0.003	1.22	1.04–1.43	0.002
Baseline LVEDVa	1.02	1.00–1.04	0.018
Pericardial Effusion	0.18	0.04–0.80	0.024
Baseline increased CRP	0.089	0.02–0.39	0.001

SBP, systolic blood pressure; EF, ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; MR, mitral regurgitation; RFP, restrictive filling pattern; TAPSE, tricuspid annular plane systolic excursion; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; CRP, C-reactive protein; EMB, endomyocardial biopsy;

^a. Odds ratio estimation is referred to every unit increase for continuous variables.